Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

# AGENCY:

 Food and Drug Administration, HHS.

# ACTION:

 Notice.

This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). At least one portion of the meeting will be closed to the public.

*Name of Committee*:  Nonprescription Drugs Advisory Committee.                

*General Function of the Committee*:  To provide advice and recommendations to the agency on FDA's regulatory issues.                

*Date and Time*:  The meeting will be held on October 20, 2005, from 8 a.m. to 5:30 p.m., and on October 21, 2005, from 8 a.m. to 12 noon.                

*Location*:  Holiday Inn Washington Silver Spring, The Ballrooms, 8777 Georgia Ave., Silver Spring, MD.  The hotel telephone number is 301-589-0800.                

*Contact Person*:  Darrell Lyons, Center for Drug Evaluation and Research (HFD-021), Food and Drug Administration, 5600 Fishers Lane (for express delivery,  5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-6760, FAX: 301-827-6778, e-mail:                     *lyonsd@cder.fda.gov*, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512541.  Please call the Information Line for up-to-date information on this meeting.                

*Agenda*:   The committee will discuss the benefits and risks of antiseptic products marketed for consumer use (e.g., antibacterial hand-washes and body-washes).  The discussion will include topics such as the efficacy of antiseptics intended for use by consumers and potential risks to the individual and the general population from using these products. The background material will become available no later than the day before the meeting and will be posted under the Nonprescription Drugs Advisory Committee (NDAC) on FDA's Web site at                     *http://www.fda.gov/​ohrms/​dockets/​ac/​acmenu.htm*.  (Click on the year 2005 and scroll down to NDAC).                

*Procedure*:   On October 20, 2005, from 8 a.m. to 5:30 p.m., the meeting is open to the public.  Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee.  Written submissions may be made to the contact person by October 13, 2005.  Oral presentations from the public will be scheduled between approximately 1 p.m. and 2 p.m. on October 20, 2005.  Time allotted for each presentation may be limited.  Those desiring to make formal oral presentations should notify the contact person before October 13, 2005, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation.                

*Closed Committee Deliberations*:   On October 21, 2005, from 8 a.m. to 12 noon, the meeting will be closed to permit discussion and review of trade secret and/or confidential information (5 U.S.C. 552b(c)(4)).                

                    Persons attending FDA's advisory committee meetings are advised that the                           ( print page 54561)                        agency is not responsible for providing access to electrical outlets.                

FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact LaNise Giles at 301-827-7001, at least 7 days in advance of the meeting.

Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).

Dated: September 8, 2005.

Scott Gottlieb,

Deputy Commissioner for Policy.

[FR Doc. 05-18366 Filed 9-14-05; 8:45 am]

BILLING CODE 4160-01-S